Follicular lymphoma: Expanding therapeutic options - The Ganti/Bociek/Bierman et al article reviewed

被引:0
作者
Van Gelder, M [1 ]
Schouten, HC [1 ]
机构
[1] Univ Hosp Maastricht, Dept Internal Med, Hematol Oncol Sect, Maastricht, Netherlands
来源
ONCOLOGY-NEW YORK | 2005年 / 19卷 / 02期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:234 / 235
页数:2
相关论文
共 5 条
  • [1] SCHOUTEN HC, 1988, BONE MARROW TRANSPL, V3, P407
  • [2] High-dose, therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: Results from the randomized European CUP trial
    Schouten, HC
    Qian, W
    Kvaloy, S
    Porcellini, A
    Hagberg, H
    Johnsen, HE
    Doorduijn, JK
    Sydes, MR
    Kvalheim, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) : 3918 - 3927
  • [3] Activation and suppression of the TRAIL death-receptor pathway in chemotherapy sensitive and resistant follicular lymphoma cells
    Wagner, KW
    King, F
    Nomoto, K
    Knee, DA
    Hampton, G
    Nasoff, M
    Deveraux, QL
    [J]. CANCER BIOLOGY & THERAPY, 2003, 2 (05) : 534 - 540
  • [4] A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia
    Wulf, GG
    Wang, RY
    Kuehnle, I
    Weidner, D
    Marini, F
    Brenner, MK
    Andreeff, M
    Goodell, MA
    [J]. BLOOD, 2001, 98 (04) : 1166 - 1173
  • [5] B-cell non-Hodgkin's lymphoma: Evidence for the t(14; 18) translocation in all hematopoietic cell lineages
    Yarkoni, S
    Lishner, M
    Tangi, I
    Nagler, A
    LorberboumGalski, H
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (14) : 973 - 979